IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 192 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,485,437 | -17.0% | 154,251 | -8.3% | 0.00% | -33.3% |
| Q2 2023 | $1,789,627 | -1.2% | 168,198 | -2.3% | 0.00% | 0.0% |
| Q1 2023 | $1,810,860 | -16.2% | 172,135 | -1.3% | 0.00% | 0.0% |
| Q4 2022 | $2,161,683 | +20.6% | 174,470 | +0.8% | 0.00% | 0.0% |
| Q3 2022 | $1,793,000 | -14.3% | 173,110 | -4.5% | 0.00% | 0.0% |
| Q2 2022 | $2,091,000 | -14.6% | 181,361 | -6.8% | 0.00% | 0.0% |
| Q1 2022 | $2,448,000 | -0.5% | 194,568 | -7.8% | 0.00% | 0.0% |
| Q4 2021 | $2,460,000 | -7.7% | 211,014 | +3.4% | 0.00% | 0.0% |
| Q3 2021 | $2,665,000 | +3.3% | 204,070 | +1.8% | 0.00% | 0.0% |
| Q2 2021 | $2,580,000 | -4.1% | 200,469 | -16.7% | 0.00% | -25.0% |
| Q1 2021 | $2,690,000 | -2.1% | 240,626 | -0.3% | 0.00% | 0.0% |
| Q4 2020 | $2,748,000 | +26.6% | 241,259 | 0.0% | 0.00% | +33.3% |
| Q3 2020 | $2,170,000 | -11.5% | 241,259 | +1.6% | 0.00% | -25.0% |
| Q2 2020 | $2,451,000 | +2.3% | 237,464 | 0.0% | 0.00% | -20.0% |
| Q1 2020 | $2,396,000 | -23.3% | 237,464 | +1.2% | 0.01% | 0.0% |
| Q4 2019 | $3,124,000 | +51.9% | 234,741 | -2.0% | 0.01% | +25.0% |
| Q3 2019 | $2,056,000 | -20.6% | 239,483 | +1.2% | 0.00% | -20.0% |
| Q2 2019 | $2,589,000 | -11.2% | 236,622 | +9.9% | 0.01% | -16.7% |
| Q1 2019 | $2,914,000 | +27.8% | 215,400 | -2.2% | 0.01% | +20.0% |
| Q4 2018 | $2,281,000 | -41.7% | 220,189 | +3.9% | 0.01% | -37.5% |
| Q3 2018 | $3,912,000 | -3.5% | 211,940 | -0.0% | 0.01% | 0.0% |
| Q2 2018 | $4,054,000 | +28.2% | 212,015 | +3.4% | 0.01% | +14.3% |
| Q1 2018 | $3,162,000 | -0.6% | 204,946 | -3.5% | 0.01% | 0.0% |
| Q4 2017 | $3,182,000 | -6.4% | 212,298 | -1.5% | 0.01% | -12.5% |
| Q3 2017 | $3,398,000 | -24.6% | 215,473 | -9.7% | 0.01% | -20.0% |
| Q2 2017 | $4,506,000 | +3.7% | 238,639 | -6.3% | 0.01% | +11.1% |
| Q1 2017 | $4,347,000 | +6.5% | 254,810 | -4.5% | 0.01% | +12.5% |
| Q4 2016 | $4,080,000 | -6.2% | 266,810 | -2.6% | 0.01% | -11.1% |
| Q3 2016 | $4,348,000 | +22.4% | 273,810 | +0.8% | 0.01% | +12.5% |
| Q2 2016 | $3,553,000 | +21.4% | 271,710 | +1.6% | 0.01% | +33.3% |
| Q1 2016 | $2,927,000 | +8.2% | 267,522 | +14.6% | 0.01% | -14.3% |
| Q4 2015 | $2,704,000 | +13.0% | 233,338 | +1.6% | 0.01% | +16.7% |
| Q3 2015 | $2,393,000 | -13.7% | 229,611 | -0.2% | 0.01% | -14.3% |
| Q2 2015 | $2,774,000 | -20.7% | 230,011 | +5.2% | 0.01% | -12.5% |
| Q1 2015 | $3,497,000 | +2.7% | 218,577 | -1.6% | 0.01% | 0.0% |
| Q4 2014 | $3,404,000 | +1.4% | 222,177 | -14.2% | 0.01% | 0.0% |
| Q3 2014 | $3,356,000 | +0.3% | 259,025 | +18.7% | 0.01% | 0.0% |
| Q2 2014 | $3,345,000 | +40.5% | 218,182 | +12.9% | 0.01% | +33.3% |
| Q1 2014 | $2,381,000 | +21.8% | 193,282 | +14.8% | 0.01% | +20.0% |
| Q4 2013 | $1,955,000 | -1.4% | 168,382 | +0.6% | 0.01% | -16.7% |
| Q3 2013 | $1,983,000 | +22.9% | 167,382 | +3.2% | 0.01% | +20.0% |
| Q2 2013 | $1,613,000 | -32.5% | 162,148 | +24.1% | 0.01% | -37.5% |
| Q1 2013 | $2,389,000 | – | 130,616 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,520,000 | $19,562,000 | 18.54% |
| Sarissa Capital Management LP | 16,390,000 | $210,939,000 | 16.77% |
| Healthcare Value Capital, LLC | 200,000 | $2,574,000 | 5.13% |
| Camber Capital Management LP | 7,500,000 | $96,525,000 | 3.25% |
| 13D Management LLC | 650,455 | $8,371,000 | 2.88% |
| BRIDGER MANAGEMENT, LLC | 2,035,114 | $26,192,000 | 2.44% |
| Brown Capital Management | 18,484,759 | $237,899,000 | 1.80% |
| Healthcare Value Capital, LLC | 50,000 | $644,000 | 1.28% |
| Zebra Capital Management LLC | 53,359 | $687,000 | 0.80% |
| PRICE MICHAEL F | 520,000 | $6,692,000 | 0.74% |